3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
101
Neoplasms, Plasma Cell
12
Recurrence
9
Lymphoma
8
Immunoglobulin Light-chain Amyloidosis
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Leukemia, Myeloid, Acute
5
Lymphoma, Mantle-Cell
4
Waldenstrom Macroglobulinemia
3
Paraproteinemias
3
Hematologic Neoplasms
3
Amyloidosis
3
Renal Insufficiency
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Burkitt Lymphoma
2
beta-Thalassemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Plasmacytoma
1
Plasmablastic Lymphoma
1
Peripheral Nervous System Diseases
1
Interventions
fludarabine
7
Cyclophosphamide
7
fludarabine phosphate
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
pembrolizumab
1
ibrutinib
1
Surveys and Questionnaires
1
CA-4948
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immune System Diseases
×
Bortezomib
×
1 year
×
Clear all
No trials found.